The global silent heart attack market is expected to grow at a CAGR of 5.7% during the forecast
period. Silent heart attack is a condition which has no or very less symptoms. Major risk factors
of silent heart attacks are smoking or chewing tobacco, high cholesterol, high blood pressure,
diabetes, and obesity. MRI, cardiac CT scan, electrocardiogram, echocardiogram are used of the
diagnosis of silent heart attack. The condition can be treated through medications, coronary
angioplasty & stenting, and coronary artery bypass surgery.
Request Sample Copy:
Prevalence of chronic diseases such as cardiovascular diseases, obesity and diabetes is on the
rise across the globe, especially in the developing countries. The market is driven by the
increasing prevalence of cardiovascular diseases in rural areas of the developing countries.
Additionally, increasing research and development activities, and technological advancements
to identify the causes and risk factors for chronic heart diseases is fuelling the global silent
heart attack market growth. High cost of treatment may restrain the growth of the market.
According to WHO, more than 35% of the total global population were suffering from major or
minor cardiovascular complication in 2015 and is the number one cause of death globally.
The global Silent Heart Attack market is segmented on the basis of type, indication, devices, and
On the basis of type, market is segmented into spirometry, gas diffusion test, body
plethysmograph, bronchial provocation test, and others.
On the basis of indication, the market is segmented into asthma, chronic bronchitis, respiratory
infections, chronic obstructive pulmonary disease, cystic fibrosis, pneumonia, lung cancer, and
On the basis of devices, the market is segmented into spirometer, breath CO monitor,
oscillometer, ergospirometer, dose controlled drug nebulizer, and others.
On the basis of end